Veterinary finance firms engaged in partnerships with biotech companies for advanced treatments are showing improved market sentiment, reflected in stronger short-term technical indicators. More than ever, Americans regard pets as family. In a recent survey by Trust & Will , 62% of respondents stated that pets and humans should receive the same treatment in estate plans. However, even those in the highest-earning households face affordability challenges: 27% of pet owners earning more than $90,000 who have declined or avoided care say they did so because they could not afford it. Dividend yields in certain veterinary finance companies are rising, appealing to income-focused investors looking for stability in specialized healthcare markets.